LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 1 | 70.81 | 84.90 | 1434 | 9132 | 0.1570 | 0.5202 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 70.81 | 84.90 | 1448 | 9132 | 0.1586 | 0.5224 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 70.81 | 84.90 | 1421 | 9132 | 0.1556 | 0.5182 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 70.81 | 84.90 | 1435 | 9132 | 0.1571 | 0.5204 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 72.52 | 84.90 | 1404 | 9214 | 0.1524 | 0.5142 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 72.52 | 84.90 | 1424 | 9214 | 0.1545 | 0.5174 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 72.52 | 84.90 | 1441 | 9214 | 0.1564 | 0.5201 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 72.52 | 84.90 | 1457 | 9214 | 0.1581 | 0.5226 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 74.22 | 84.90 | 1468 | 9343 | 0.1571 | 0.5224 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 74.22 | 84.90 | 1491 | 9343 | 0.1596 | 0.5258 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 74.22 | 84.90 | 1450 | 9343 | 0.1552 | 0.5196 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 74.22 | 84.90 | 1465 | 9343 | 0.1568 | 0.5219 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 75.93 | 84.90 | 1442 | 8970 | 0.1608 | 0.5239 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 75.93 | 84.90 | 1462 | 8970 | 0.1630 | 0.5270 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 75.93 | 84.90 | 1440 | 8970 | 0.1605 | 0.5236 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 75.93 | 84.90 | 1454 | 8970 | 0.1621 | 0.5258 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 77.64 | 84.90 | 1398 | 9245 | 0.1512 | 0.5128 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 77.64 | 84.90 | 1425 | 9245 | 0.1541 | 0.5171 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 77.64 | 84.90 | 1439 | 9245 | 0.1556 | 0.5193 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 77.64 | 84.90 | 1454 | 9245 | 0.1573 | 0.5216 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 79.34 | 84.90 | 1406 | 9051 | 0.1553 | 0.5170 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 79.34 | 84.90 | 1428 | 9051 | 0.1578 | 0.5205 | MN20160318_Q02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 79.34 | 84.90 | 1440 | 9051 | 0.1591 | 0.5224 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 79.34 | 84.90 | 1453 | 9051 | 0.1605 | 0.5244 | MN20160318_Q02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 81.05 | 84.90 | 1426 | 8863 | 0.1609 | 0.5230 | MN20160318_Q02 | I09 |